Sean Lee CFA

Stock Analyst at H.C. Wainwright

(0.35)
# 4,285
Out of 4,574 analysts
258
Total ratings
28.3%
Success rate
-3.7%
Average return
Main Sectors:

Stocks Rated by Sean Lee CFA

Akari Therapeutics,
Jul 1, 2026
Reiterated: Buy
Price Target: $27
Current: $8.70
Upside: +210.34%
Corvus Pharmaceuticals
Jul 1, 2026
Reiterated: Buy
Price Target: $27
Current: $13.07
Upside: +106.58%
Dogwood Therapeutics
Jul 1, 2026
Reiterated: Buy
Price Target: $12
Current: $1.50
Upside: +700.00%
Senseonics Holdings
Jun 24, 2026
Reiterated: Buy
Price Target: $14
Current: $4.86
Upside: +188.07%
Kazia Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $12.26
Upside: +46.82%
Cytosorbents
May 14, 2026
Reiterated: Hold
Price Target: $0.75
Current: $0.36
Upside: +108.33%
Myomo
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $0.97
Upside: +415.46%
Alphatec Holdings
May 7, 2026
Reiterated: Buy
Price Target: $24
Current: $8.26
Upside: +190.56%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $7.46
Upside: +114.48%
Plus Therapeutics
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $3.83
Upside: +552.74%
Maintained: Buy
Price Target: $4
Current: $0.1288
Upside: +3,005.59%
Reiterated: Buy
Price Target: $14
Current: $6.05
Upside: +131.40%
Maintained: Buy
Price Target: €14.00
Current: €3.16
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $1.78
Upside: n/a
Maintained: Buy
Price Target: $40
Current: $109.87
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a